Contact this trialFirst, we need to learn more about you.
Neurokinin Antagonist
Elinzanetant for Hot Flashes
Recruiting1 awardPhase 3
Little Rock, Arkansas
This trial is testing a new medication called elinzanetant to help women who have hot flashes after menopause. The medication works by blocking signals that cause hot flashes. Researchers will track the number and severity of hot flashes over time.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service